More than 60 rheumatologists and medical professionals from across the globe attended the sixth annual James and Nancy Cassidy Rheumatology Symposium in Columbia, Missouri — an event sponsored by the University of Missouri School of Medicine.
“This symposium is a treasure trove,” said Anjali Patwardhan, MD, chair and organizer of the event, and Director of the Pediatric Rheumatology division at the MU School of Medicine. “It is the only annual Pediatric Rheumatology symposium in the United States. We are privileged to have drawn the attention of world leaders in rheumatology and invite them as speakers here in Mid-Missouri. Their presentations steer the field forward.”
Patwardhan said she is passionate about teaching and learning, and this event provides an opportunity for rheumatologists to share knowledge across borders and specialties.
The 2018 symposium featured six lectures:
- “Childhood Vasculitis: Novel Approaches in Therapy”
Susa Bensler, MD, PhD, Associate Professor, University of Calgary Department of Pediatrics.
- “Chronic Pain in Children; Management Approach”
David Sherry, MD, Attending Rheumatologist and Director of the Amplified Pain Program, Children’s Hospital of Philadelphia.
- “Timing and Effect of Stopping Biological Therapies in Children With JIA in Clinical Inactive Disease”
Daniel Lovell, MD, MPH, Associate Director, Division of Rheumatology, Cincinnati Children’s Hospital Medical Center.
- “TMJ Arthritis”
Randy Cron, MD, PhD, Director, Division of Pediatric Rheumatology, University of Alabama.
- “Hypermobile Joint Syndrome and its Possible Relationship with JIA”
Francesco Zulian, MD, Director, Pediatric Rheumatology Unit, University of Padua, Italy.
- “Hypermobility: Consequences and Management”
Kevin Baszis, MD, Assistant Professor of Pediatrics, Rheumatology, Washington University School of Medicine in St. Louis.
Patwardhan said a key to the symposium’s success has been collaborating with the rheumatological community to develop each year’s agenda. She also said Paula Partridge, Patricia Walch, LPN, and Deborah Lowry, LPN, each play a pivotal role in bringing the annual event to life.
“This event is going to continue to grow as directed by the audience and their academic needs,” she said. “We’ve made a lot of changes over the years, and we will keep doing so every year to ensure the content and format remains relevant and valuable.”
Patwardhan said she has already finalized the speaker list for 2019’s symposium. She also noted that the event is accredited by the American Board of Pediatrics, meaning any doctor, nurse or therapist interested in rheumatology could earn CME and MOC points for attending.